# OnCo record metastasis-free-survival (term). Data CC BY-NC 4.0, attribute "Data from OnCo (onco.cc)". Whole corpus: https://onco.cc/api/v1/onco.nt
@prefix schema: <https://schema.org/> .
@prefix onco: <https://onco.cc/ns#> .
@prefix xsd: <http://www.w3.org/2001/XMLSchema#> .

<https://onco.cc/terms/metastasis-free-survival/>
  a schema:DefinedTerm ;
  onco:kind "term" ;
  schema:identifier "metastasis-free-survival" ;
  schema:name "Metastasis-free survival (MFS)"@en ;
  schema:alternateName "MFS"@en, "metastasis free survival"@en, "time to first metastasis"@en, "distant metastasis-free survival"@en, "DMFS"@en ;
  schema:description "The time from joining a trial until a scan first shows the cancer has spread, or the man dies, whichever comes first. It is the endpoint that got three hormone drugs licensed for prostate cancer that had not yet spread, because waiting for deaths would have taken another decade."@en ;
  schema:url <https://onco.cc/terms/metastasis-free-survival/> ;
  schema:dateModified "2026-09-25"^^xsd:date ;
  schema:citation <https://doi.org/10.1200/jco.2017.73.9987>, <https://doi.org/10.1056/nejmoa1715546>, <https://doi.org/10.1200/jco.2015.64.2702> ;
  onco:tag "gu", "prostate-glossary" ;
  onco:related <https://onco.cc/terms/radiographic-progression-free-survival/>, <https://onco.cc/terms/psa-doubling-time/>, <https://onco.cc/trials/prosper/>, <https://onco.cc/trials/aramis/>, <https://onco.cc/trials/embark/>, <https://onco.cc/terms/hazard-ratio/> ;
  onco:cancers <https://onco.cc/cancers/prostate/>, <https://onco.cc/cancers/prostate-high-risk/>, <https://onco.cc/cancers/prostate-bcr/>, <https://onco.cc/cancers/prostate-nmcrpc/>, <https://onco.cc/cancers/prostate-mhspc/> ;
  onco:sections <https://onco.cc/fronts/hormonal/>, <https://onco.cc/fronts/imaging/> ;
  onco:technologies <https://onco.cc/technologies/psma-pet/>, <https://onco.cc/technologies/pet/> ;
  onco:terms <https://onco.cc/terms/radiographic-progression-free-survival/>, <https://onco.cc/terms/psa-doubling-time/>, <https://onco.cc/terms/hazard-ratio/>, <https://onco.cc/terms/castration-resistance/>, <https://onco.cc/terms/biochemical-recurrence/>, <https://onco.cc/terms/tnm-prostate-cancer/> ;
  onco:bottlenecks <https://onco.cc/bottlenecks/b-trial-design/>, <https://onco.cc/bottlenecks/b-regulatory-fragmentation/>, <https://onco.cc/bottlenecks/b-early-detection/> ;
  onco:keyPapers <https://onco.cc/key-papers/paper-uspstf-prostate-screening-jama-2018/> .